Skip to main content

Table 2 Assessment of breast changes (skin erythema) during the treatment course and clinical follow-up at 3 months

From: Three-dimensional surface imaging in breast cancer: a new tool for clinical studies?

Timepointbaselineweek 1week 2week 3week 4week 5week 6week 7follow-up
Overall0.02.914.736.877.3100.0100.066.73.7
CF-RT0.00.07.746.792.9100.0100.066.70.0
HF-RT0.04.819.030.450.0NANANA5.6
  1. All results are expressed in percent of patients (n = 38)